Galixir
PrivateLast Round
VC Round
Aug 4, 2021
Total Funding Raised
$10M
Company Overview
Galixir operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in August 2021.
Galixir is a biotechnology company that leverages artificial intelligence to accelerate preclinical drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galixir Comparables
Compare Galixir with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 91% | |
| StoneWise | 88% | |
| Genesis Molecular AI | 85% |
For institutional investors. Book with your work email.
Galixir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 4, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Aug 17, 2020 | ||||
| Angel | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Galixir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCM Ventures | Series A Extension, Series A, VC Round, Pre Seed |
| 5Y Capital | VC Round, Pre Seed, Series A Extension, Series A |
| Source Code Capital | Series A Extension, Series A, VC Round, Pre Seed |
| ACE Redpoint Ventures | VC Round, Series A Extension, Series A |
| BAI Capital | Series A Extension, Series A, VC Round |
| Gaorong Capital | Angel, Series A Extension, Series A, VC Round, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2020
Led by 5Y Capital and ACE Redpoint Ventures.
- Nov 1, 2019
Raised an Angel round with Gaorong Capital participating.
For institutional investors. Book with your work email.
Galixir Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Galixir's valuation, stock price, and market status.
Is Galixir a public or private company?
Galixir is a private company.
What is the current stock price of Galixir?
Galixir is a private company, so its shares have no public market price. Caplight tracks Galixir's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Galixir worth (valuation)?
Valuation information for Galixir is not publicly available.
Can I buy Galixir stock?
Galixir shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Galixir's last funding round?
Galixir's most recent funding round was VC Round on August 4, 2021.
Who are the main investors in Galixir?
Key investors in Galixir include DCM Ventures, 5Y Capital, Source Code Capital, ACE Redpoint Ventures.
Will Galixir IPO soon?
No public IPO plans have been announced for Galixir.
How can I track Galixir secondary market activity?
Caplight tracks bids, offers, and trades in Galixir's shares on secondary markets.